DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ad0c22/pathophysiology_p) has announced the addition of Elsevier Science and Technology's new report "Pathophysiology, pharmacology and biochemistry of dyskinesia" to their offering.

Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia. Key Features

Leading authors review state-of-the-art in their field of investigation and provide their views and perspectives for future research Chapters are extensively referenced to provide readers with a comprehensive list of resources on the topics covered All chapters include comprehensive background information and are written in a clear form that is also accessible to the non-specialist

Topics Covered:

An introduction to dyskinesia: the clinical spectrum L-dopa induced dyskinesia - clinical presentation, genetics and treatment Experimental models of LID Mechanisms underlying LID Novel approaches to therapy Surgical approaches to LID Tardive dyskinesia - clinical presentation and treatment Epidemiology and risk factors for TD Genetics of TD Heon Experimental models of TD Surgical approaches to TD Huntington's chorea - clinical presentation and treatment Genetics and pathology of HD Pathogenic mechanisms in HD Experimental models of HD and novel therapeutic approaches Cell based treatments for HD Clinical phenomenology of dystonia Genetics and pharmacological treatment of dystonia Experimental models of dystonia Surgical treatment of dystonia

For more information visit http://www.researchandmarkets.com/research/ad0c22/pathophysiology_p

Read the original here:
Research and Markets: Pathophysiology, Pharmacology and Biochemistry of Dyskinesia